Literature DB >> 35518569

Corrigendum to "Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study".

Sylvia J Kroese1, Carolien N H Abheiden2, Birgit S Blomjous2,3, Jacob M van Laar1, Ronald W H M Derksen1, Irene E M Bultink3, Alexandre E Voskuyl3, A Titia Lely4, Marjon A de Boer2, Johanna I P de Vries2, Ruth D E Fritsch-Stork1,5,6,7.   

Abstract

[This corrects the article DOI: 10.1155/2017/8245879.].
Copyright © 2022 Sylvia J. Kroese et al.

Entities:  

Year:  2022        PMID: 35518569      PMCID: PMC9064495          DOI: 10.1155/2022/9828675

Source DB:  PubMed          Journal:  J Immunol Res        ISSN: 2314-7156            Impact factor:   4.493


In the article titled “Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study” [1], the authors identified some discrepancies in the data following its publication. There are very small changes in incidence of HELLP syndrome (N = 5 instead of N = 7), preeclampsia (N = 22 instead of 24), and mild hypertensive disorder (N = 19 instead of 21), which showed no significant difference in the preeclampsia group. The incidence of preeclampsia <34 weeks, eclampsia, and HELLP syndrome were too low to conduct the generalized estimating equations (GEE) analysis; therefore, a new p value cannot be produced. Due to the very small differences, we believe that our conclusions are not changed. As already described on page 6 of the article: “In our cohort, we only found an association with APS and HELLP. However, considering the low numbers of HELLP in the paper by Moroni et al. (2 out of 71 pregnancies = 2.6%) and our study (7 out of 144 pregnancies = 4.9%), we do not venture to interpret these findings.” The corrected Table 3 is shown below.
Table 3

Maternal and perinatal pregnancy complications in all study pregnancies.

TotalSLE-aPLSLE + aPLSLE + APS p value
Maternal complications N = 144 N = 117 N = 14 N = 13
Mild HD19/144 (13.2)16/117 (13.7)1/14 (7.1)2/13 (15.4)ns
Severe HD24/144 (16.7)18/117 (15.4)2/14 (14.3)4/13 (30.8)ns
 Preeclampsia22/141 (15.6)17/114 (14.9)2/14 (14.3)3/13 (23.1)ns
 Onset preeclampsia <34 weeks8/22 (36.4)7/17 (41.2)1/3 (33.3)0 (0)
 Eclampsia1/140 (0.7)1/113 (0.9)0/14 (0)0/13 (0)
 HELLP syndrome5/144 (3.5)3/117 (2.6)0/14 (0)2/13 (15.4)
Perinatal complications n = 147 n = 119 n = 15 n = 13
IUFD6/147 (4.1)6/1190/150/13ns
Preterm birth48/147 (32.7)40/119 (33.6)4/15 (26.7)4/13 (30.8)ns
SGA infant21/142 (14.8)18/115 (15.7)2/15 (13.3)1/12 (8.3)ns
Neonatal lupus2/147 (1.4)2/119 (1.7)0/15 (0)0/13 (0)ns
Additionally, in Section 3.3.2, the sentence “Of all preterm births (<37 weeks), 44.2% occurred spontaneously, and in the others, labour was induced. Main indications for preterm induction of labour (<37 weeks) were HD (54.1%) and IUFD (12.5%).” should be corrected to “Of all preterm births (<37 weeks), 61.9% occurred spontaneously. Main indications for preterm induction of labor (<37 weeks) were HD (30.8%) and IUGR (23.1%). IUFD as reason for preterm induction of labor occurred once (7.7%).” Also, the email address of the corresponding author should be changed to “s.kroese@hagaziekenhuis.nl.” The authors confirm that this does not affect the results and conclusions of the article, and the editorial board agrees to the publication of a corrigendum.
  1 in total

1.  Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study.

Authors:  Sylvia J Kroese; Carolien N H Abheiden; Birgit S Blomjous; Jacob M van Laar; Ronald W H M Derksen; Irene E M Bultink; Alexandre E Voskuyl; A Titia Lely; Marjon A de Boer; Johanna I P de Vries; Ruth D E Fritsch-Stork
Journal:  J Immunol Res       Date:  2017-09-28       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.